CID 155269708

Inlexisertib

Structural Information

Molecular Formula
C26H36F3N7O2
SMILES
CCC1=C(C=CC(=C1)N2CCN(CC2)C)NC3=NC=C(C(=N3)NCCCN4CCOCCC4=O)C(F)(F)F
InChI
InChI=1S/C26H36F3N7O2/c1-3-19-17-20(35-12-10-34(2)11-13-35)5-6-22(19)32-25-31-18-21(26(27,28)29)24(33-25)30-8-4-9-36-14-16-38-15-7-23(36)37/h5-6,17-18H,3-4,7-16H2,1-2H3,(H2,30,31,32,33)
InChIKey
CNBTYICEJGEABG-UHFFFAOYSA-N
Compound name
4-[3-[[2-[2-ethyl-4-(4-methylpiperazin-1-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]propyl]-1,4-oxazepan-5-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

20
Patents

535.28827 Da
Monoisotopic Mass

3.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 536.29555 227.2
[M+Na]+ 558.27749 232.6
[M+NH4]+ 553.32209 227.5
[M+K]+ 574.25143 228.6
[M-H]- 534.28099 227.7
[M+Na-2H]- 556.26294 229.0
[M]+ 535.28772 227.5
[M]- 535.28882 227.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe